Millennium Management’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.43M | Sell |
551,349
-9,761
| -2% | -$52.7K | ﹤0.01% | 3681 |
|
|
2025
Q4 | $3.57M | Sell |
561,110
-213,127
| -28% | -$1.48M | ﹤0.01% | 3382 |
|
|
2025
Q3 | $7.22M | Buy |
774,237
+652,684
| +537% | +$6.59M | 0.01% | 2731 |
|
|
2025
Q2 | $1.75M | Sell |
121,553
-479,347
| -80% | -$4.73M | ﹤0.01% | 3995 |
|
|
2025
Q1 | $4.15M | Buy |
600,900
+374,811
| +166% | +$2.36M | ﹤0.01% | 3053 |
|
|
2024
Q4 | $1.2M | Buy |
+226,089
| New | +$1.24M | ﹤0.01% | 4050 |
|
|
2024
Q3 | – | Sell |
-192,341
| Closed | -$525K | – | 6763 |
|
|
2024
Q2 | $525K | Sell |
192,341
-391,941
| -67% | -$1.31M | ﹤0.01% | 4552 |
|
|
2024
Q1 | $2.03M | Buy |
584,282
+459,186
| +367% | +$850K | ﹤0.01% | 3720 |
|
|
2023
Q4 | $179K | Sell |
125,096
-105,601
| -46% | -$147K | ﹤0.01% | 5212 |
|
|
2023
Q3 | $337K | Sell |
230,697
-50,376
| -18% | -$78.7K | ﹤0.01% | 4870 |
|
|
2023
Q2 | $441K | Sell |
281,073
-231,839
| -45% | -$346K | ﹤0.01% | 4630 |
|
|
2023
Q1 | $785K | Sell |
512,912
-149,955
| -23% | -$267K | ﹤0.01% | 4304 |
|
|
2022
Q4 | $1.11M | Buy |
662,867
+462,204
| +230% | +$733K | ﹤0.01% | 4053 |
|
|
2022
Q3 | $247K | Sell |
200,663
-562,930
| -74% | -$906K | ﹤0.01% | 5512 |
|
|
2022
Q2 | $1.27M | Buy |
+763,593
| New | +$1.49M | ﹤0.01% | 4154 |
|
|
2022
Q1 | – | Sell |
-225,920
| Closed | -$845K | – | 7752 |
|
|
2021
Q4 | $845K | Buy |
225,920
+72,852
| +48% | +$393K | ﹤0.01% | 4556 |
|
|
2021
Q3 | $960K | Buy |
153,068
+50,850
| +50% | +$419K | ﹤0.01% | 4737 |
|
|
2021
Q2 | $1.01M | Sell |
102,218
-806,695
| -89% | -$7.03M | ﹤0.01% | 4659 |
|
|
2021
Q1 | $8.49M | Buy |
908,913
+812,958
| +847% | +$6.44M | 0.01% | 1970 |
|
|
2020
Q4 | $461K | Sell |
95,955
-107,091
| -53% | -$522K | ﹤0.01% | 4251 |
|
|
2020
Q3 | $814 | Buy |
203,046
+103,997
| +105% | +$502K | ﹤0.01% | 3277 |
|
|
2020
Q2 | $455K | Buy |
+99,049
| New | +$443K | ﹤0.01% | 3455 |
|
|
2019
Q4 | – | Sell |
-154,733
| Closed | -$608K | – | 4716 |
|
|
2019
Q3 | $608K | Buy |
154,733
+133,985
| +646% | +$571K | ﹤0.01% | 3128 |
|
|
2019
Q2 | $96K | Buy |
+20,748
| New | +$88.5K | ﹤0.01% | 3897 |
|
|
2018
Q2 | – | Sell |
-504,525
| Closed | -$2.12M | – | 4273 |
|
|
2018
Q1 | $2.12M | Sell |
504,525
-38,469
| -7% | -$201K | ﹤0.01% | 2276 |
|
|
2017
Q4 | $3.19M | Buy |
542,994
+205,852
| +61% | +$1.11M | ﹤0.01% | 1994 |
|
|
2017
Q3 | $1.45M | Sell |
337,142
-22,403
| -6% | -$81.9K | ﹤0.01% | 2332 |
|
|
2017
Q2 | $1.37M | Buy |
359,545
+204,010
| +131% | +$646K | ﹤0.01% | 2292 |
|
|
2017
Q1 | $418K | Sell |
155,535
-73,547
| -32% | -$209K | ﹤0.01% | 2899 |
|
|
2016
Q4 | $758K | Buy |
+229,082
| New | +$622K | ﹤0.01% | 2412 |
|
Other funds holding NAGE
SW
VCM
TCM
